Related Experiment Video
Updated: Aug 13, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Interventional Tricuspid Valve Replacement: A Structured Sequence of Procedures
Sven Möbius-Winkler1, Ali Hamadanchi2, Aurel Maloku2
1Dept. of Internal Medicine I, Cardiology, Angiology, Intensive Medical Care, University Hospital Jena; sven.moebius-winkler@med.uni-jena.de.
Abstract:
The EVOQUE valve system is the first approved tricuspid valve replacement system developed specifically for the percutaneous implantation of a biological tricuspid valve in patients diagnosed with symptomatic severe tricuspid regurgitation (TR). The implantation procedure is performed through the introduction and advancement of the valve delivery system via the femoral vein. The prosthetic valve consists of a Nitinol frame with a valve made from bovine pericardium. The entire implantation procedure is performed completely percutaneously. Each step of valve positioning, deployment, and implantation is performed while the patient is under general anesthesia. The procedure is carried out under close observation and precise steering using continuous guidance with transesophageal echocardiography (TEE). This protocol presents a comprehensive and detailed step-by-step approach to the interventional endovascular implantation of the EVOQUE tricuspid bioprosthesis under TOE guidance. The procedure has been demonstrated to be both safe and efficient, with most patients achieving complete resolution of tricuspid regurgitation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Mitral Valve Prolapse II: Assessment and Management
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation III: Medical Management
